Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma

Clinical Trial ID NCT00294632

PubWeight™ 2.25^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00294632

Top papers